African Swine Fever Vaccine Progress Takes Major Step Forward

At the Plum Island Animal Disease Center in Orient Point, NY, ARS microbiologists Douglas Gladue (left) and Manuel Borca work on developing candidate vaccines against African swine fever virus.
At the Plum Island Animal Disease Center in Orient Point, NY, ARS microbiologists Douglas Gladue (left) and Manuel Borca work on developing candidate vaccines against African swine fever virus.
((Photo by Kathleen Apicelli, PIADC))

An African swine fever (ASF) virus vaccine candidate has been adapted to grow in a cell line, which means those involved in vaccine production will no longer have to rely on live pigs and their fresh cells for vaccine production, the USDA's Agricultural Research Service (ARS) announced on May 6. 

“This opens the door for large-scale vaccine production, which is a valuable tool for the possible eradication of the virus,” senior ARS scientist Manuel Borca, DVM, said in the release.

This discovery, highlighted in the Journal of Virology, overcomes a major challenge for ASF virus vaccine manufacturing.

"The newly developed vaccine, grown in a continuous cell line — which means immortalized cells that divide continuously or otherwise indefinitely — has the same characteristics as the original vaccine produced with fresh swine cells," USDA said in a release.

The continuous cell line vaccine candidate was tested in a commercial breed of pigs, was found to be safe and protected the pigs against the virus. No negative effects were observed, USDA reports.

“Traditionally we used freshly isolated swine cells to produce vaccine candidates and this constitutes a significant limitation for large-scale production” senior ARS scientist Douglas Gladue, DVM, said in a release. “But now we can retain the vaccine characteristics while simultaneously replicating the vaccine in lab-grown cell cultures. We no longer have to rely on gathering fresh cells from live swine.”

Although, ASF is not a threat to humans and poses no risk to the food supply, it is known to cause virulent, deadly outbreaks in wild and domestic swine, causing widespread and lethal outbreaks in various countries in Eastern Europe and throughout Asia. These outbreaks have led to significant economic losses and pork shortages on local and global scales.

With no commercial vaccine currently available to prevent the virus from spreading, researchers are furiously testing vaccine candidates and looking for ways to bring a viable vaccine to the industry.

The U.S. has not experienced an outbreak of ASF, but experts predict an outbreak could cost at least $14 billion over two years and $50 billion over 10 years, USDA reports. 

This research was supported in part by an interagency agreement between the U.S. Department of Homeland Security and the U.S. Department of Agriculture. Some of the scientific personnel were part of the Plum Island Animal Disease Center Research Participation Program, administered by the Oak Ridge Institute for Science and Education. All animal studies were performed at the Plum Island Animal Disease Center, following a protocol approved by the Institutional Animal Care and Use Committee.

More from Farm Journal's PORK:

China Reports New African Swine Fever Outbreak in Inner Mongolia

African Swine Fever Virus Mutations May Pose Detection Challenges

African Swine Fever in China: A Truth Somewhere in Between, Vilsack Says

 

Latest News

Get the Facts Straight on Highly Pathogenic Avian Influenza
Get the Facts Straight on Highly Pathogenic Avian Influenza

Now that the mystery illness impacting some dairy herds has been revealed as the same strain of Highly Pathogenic Avian Influenza that has been impacting the U.S. poultry flock, pork producers are asking questions.

Merck Introduces Sequivity with Microsol Diluvac Forte Adjuvant Prescription Vaccine
Merck Introduces Sequivity with Microsol Diluvac Forte Adjuvant Prescription Vaccine

Merck Animal Health announced it has received license approval from the USDA for Sequivity with Microsol Diluvac Forte adjuvant prescription vaccine for use in gilts and sows. 

What Does the Next Generation of the Pork Industry Want?
What Does the Next Generation of the Pork Industry Want?

It’s easy to make assumptions about what others think, but recent research funded by the Indiana Pork Producers Association and the Indiana Soybean Alliance proves it’s always better to go to the source itself.

Skills Survey Reveals U.S. Agriculture & Food Industry Workforce Needs and Gaps
Skills Survey Reveals U.S. Agriculture & Food Industry Workforce Needs and Gaps

U.S. employers report challenges in finding suitable job candidates with work-ready skills to fill open roles in ag. The AgCareers.com U.S. Skills Survey offers insights, data and trends to address skill development.

AASV Foundation Announces Recipients of Hogg Scholarship
AASV Foundation Announces Recipients of Hogg Scholarship

Ashley Johnson and Jana Morgan were named the 2024 recipients of the American Association of Swine Veterinarians Foundation Hogg Scholarship.

Will The Collapse Of The Baltimore Key Bridge Impact Agriculture?
Will The Collapse Of The Baltimore Key Bridge Impact Agriculture?

Mike Steenhoek, executive director at the Soy Transportation Coalition, shares what the collapse could mean for the supply chain.